A carregar...
Enhancement of (211)At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer
(211)At is an α-emitter that has similar chemical properties to iodine and is used in targeted α-therapy. In the present study, we added ascorbic acid (AA) to (211)At solution to increase the radiochemical purity of astatide and evaluated its efficacy against differentiated thyroid cancer, which is...
Na minha lista:
| Publicado no: | J Nucl Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Society of Nuclear Medicine
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6735285/ https://ncbi.nlm.nih.gov/pubmed/30796173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.222638 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|